Marking its 30th anniversary and her enduring interest and support, philanthropist Darlene Shiley has given a $10 million gift for the clinical space expansion of the Shiley Eye Institute at UC San Diego Health.
Stuart Therapeutics, Inc. (STUART), a clinical stage, innovative ophthalmic therapeutic development company, today announced the topline results of the first in human Phase 2 clinical trial for its lead drug candidate, ST-100 in patients with dry eye disease.
The Association for Research in Vision and Ophthalmology (ARVO) today announced Joanne Wood, PhD, is the 2022 recipient of the Oberdorfer Award in Low Vision Research. Wood's body of research has made a significant contribution to health practice and policy, including advice to licensing bodies and health professionals regarding driver licensing standards, and has been translated into standards.
The Association for Research in Vision and Ophthalmology (ARVO) congratulates Magdalena Renner, MD, recipient of the 2022 Bert M. Glaser, MD Award for Innovative Research in Retina. The award recognizes an early-career investigator who has made a novel discovery that impacted the understanding and/or treatment of a retinal disease or condition.
Nixon Foundation funds effort to study and treat macular dystrophy at Shiley Eye Institute. Currently, there are no effective treatments to slow or prevent genetic condition.
Using a stem-cell-derived model, researchers have identified two drug candidates that may slow dry age-related macular degeneration (AMD), a leading cause of blindness for which no treatment exists. The scientists, from the National Eye Institute (NEI), part of the National Institutes of Health, published their findings today in Nature Communications.
Scientists have discovered that gene therapy and the diabetes drug metformin may be potential treatments for late-onset retinal degeneration (L-ORD), a rare, blinding eye disease. Researchers from the National Eye Institute (NEI), part of the National Institutes of Health generated a “disease-in-a-dish” model to study the disease. The findings are published in Communications Biology.
This news comes at a time of increased COVID-19 hospitalizations across Loyola Medicine. During the first week of December 2021, thirty-five patients with COVID-19 were admitted to Loyola University Medical Center, an increase of 169% over the same period last month.
Pediatric ophthalmologist with Shiley Eye Institute at UC San Diego Health explains why infantile cataracts are more common — and problematic — than most people realize.
In this study of 3,000 adults with cataracts, the risk of developing dementia was lower in participants who underwent cataract removal compared with those who didn’t.
During pandemic-induced isolation, researchers from the University of Minnesota surveyed older adults with vision loss, with hearing loss, or without either condition, asking the participants about their worries, well-being, and social isolation at six-week intervals. All three groups scored lower on a patient health questionnaire after the pandemic began; however, people with vision or hearing loss faced unique problems in lockdown. Disruptions to mobility systems affected people with low vision, and masks made conversations especially difficult for adults with hearing loss.
Researchers from The Australian National University (ANU) have identified unique molecular signals in the body that could hold the key to developing a supplement capable of administering the health benefits of exercise to patients incapable of physical activity.
Pernell T. Reid, MD, MHA, MS, an experienced health care administrator with nearly two decades of practice management and financial leadership experience in academic medicine, is joining Mass Eye and Ear (a member hospital of Mass General Brigham) as Senior Vice President of the Department of Otolaryngology–Head and Neck Surgery (OHNS).
Johns Hopkins Medicine researchers report they have genetically mapped the cell types that make up the mouse iris — the thin disc of pigmented tissue that, in humans, gives eyes their distinct colors.
Just three minutes of exposure to deep red light once a week, when delivered in the morning, can significantly improve declining eyesight, finds a pioneering new study by UCL researchers.
New study led by Georgia Tech's Lewis Wheaton uses prehistoric stone toolmaking to fill in the gaps on how vision and movement evolve to help people learn complicated tasks
An implant that delivers medication to the back of the eye was found to effectively treat age-related macular degeneration (AMD) for at least six months.
A new study presented today at AAO 2021, the 125th annual meeting of the American Academy of Ophthalmology, shows that even patients with mild inflammation can experience a reduction in eye bulging with Tepezza.
The American Academy of Ophthalmology recognizes that immediate sequential bilateral cataract surgery (ISBCS) has the potential for some positive implications for patients.
A new study released at AAO 2021 showed that a new kind of artificial lens allowed over 90 percent of patients to see well enough that they no longer needed glasses.
New research confirms that increased screen time did lead to more eye strain in children, as well as a more troubling eye condition called convergence insufficiency, which can cause difficulty reading.
Using data generated from patients and mice with genetic mutation for the disorder Usher syndrome, researchers from the University of Maryland School of Medicine and the National Institutes of Health documented the natural history of vision impairment in patients and identified the cell mechanism behind progressive vision loss.
New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that higher doses, longer duration of use, chronic kidney disease and Asian race could all be risk factors for retinopathy in people using hydroxychloroquine for rheumatoid arthritis.
The American Academy of Ophthalmology (AAO) and the American Society of Cataract and Refractive Surgery (ASCRS) are urging consumers to be aware of insurance policies that can limit their access to sight-saving procedures and treatments.
Diabetic retinopathy affects nearly 8 million Americans, and that number is expected to double by 2050, but knowing the risks and symptoms and seeking an early diagnosis and treatment from a retina specialist can preserve sight and virtually eliminate vision loss from the condition, according to the American Society of Retina Specialists (ASRS).
Just as bright light can illuminate the depths of a darkened room, researchers in Japan have found that blue light can be used to probe the depths of the eye and uncover areas affected by diabetic retinopathy (DR), a leading cause of blindness.
Understanding how your IOP (intraocular pressure) changes over time can help you and your doctor feel confident that your glaucoma treatment is working effectively.
A new service for people with rare eye conditions has opened at the University of Illinois Chicago College of Medicine’s Illinois Eye and Ear Infirmary. The Inherited Retinal Disease Service offers state-of-the-art evaluation and consultation for patients with inherited retinal diseases, such as retinitis pigmentosa, Best disease, cone dystrophy, macular dystrophy, Stargardt disease and others.
Nearsightedness has risen dramatically over the last 50 years. If nothing is done to help slow the increase, half the world’s population may be nearsighted by the year 2050.
An international team of researchers has broadened and deepened understanding of how inherited retinal dystrophies (IRDs) affect different populations of people and, in the process, have identified new gene variants that may cause the diseases.
On October 15th, 33 scientists and glaucoma clinicians from research institutions throughout the US and from Canada, Australia, Sweden, Singapore, Hong Kong, Japan and Germany gathered in person and virtually in New York to participate in The Glaucoma Foundation’s 27th Annual Scientific Think Tank, this year focusing on “New Vistas in Glaucoma Research.”
Mount Sinai Health System has launched the first eye stroke service in New York City to expedite the diagnosis and treatment of patients who arrive at the emergency room with eye stroke—a medical emergency that must be addressed as quickly as possible to prevent irreversible vision loss.
A new study by University of Illinois Chicago researchers shows a mechanism that stops the herpes simplex virus 1 from causing serious brain damage and death. Researchers discovered a function of a protein complex, mammalian target of rapamycin complex 2, in an antiviral defense mechanism. This protein complex limits HSV-1 virus infection through rapid activation of antiviral immunity and protects the host by preventing encephalitis — brain inflammation — and possible death due to HSV-1 infection.
After losing his sight as a college student, Sanford “Sandy” Greenberg, an emeritus trustee of The Johns Hopkins University and Johns Hopkins Medicine, vowed to end blindness “permanently and for everyone.” Now, to further that goal, the Johns Hopkins Wilmer Eye Institute has launched the Sanford and Susan Greenberg Center to End Blindness.
The American Academy of Ophthalmology board of trustees today announced the unanimous selection of Stephen D. McLeod, M.D., 57, as the Academy’s next chief executive officer (CEO).
H.R. 3173, the Improving Seniors’ Timely Access to Care Act of 2021, reached a significant milestone with over one-half of the U.S. House of Representatives co-sponsoring this commonsense, bipartisan legislation, positioning the bill for swift passage in Congress.
The American Academy of Ophthalmology urges the public to only buy decorative contacts from retailers who require a prescription and sell FDA-approved products.
The American Academy of Ophthalmology announced the public opening of its Truhlsen-Marmor Museum of the Eye®, the world’s only free, public museum dedicated to the science of sight.
A handheld screening device that detects subtle misalignment of the eyes accurately identifies children with amblyopia (lazy eye), according to a study published in the Journal of the American Association for Pediatric Ophthalmology and Strabismus.
America’s retina specialists are warning the public that millions in the US who don’t know the facts about common retinal conditions such as age-related macular degeneration (AMD) and diabetic retinopathy are at risk for preventable blindness or vision loss from these sight stealing conditions.